Hua Medicine (Shanghai) Ltd. (2552.HK) Financials

2552.HK Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 1.6 billion 515.6 million
June 30, 2025 1.6 billion 395.4 million
Dec. 31, 2024 1.6 billion 1.8 billion
June 30, 2024 1.8 billion 1.8 billion

2552.HK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 ? ?
June 30, 2025 -92.5 million 5.4 million
Dec. 31, 2024 -202.4 million 4.8 million
June 30, 2024 -244.7 million 7.9 million

2552.HK Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2025 ?
June 30, 2025 1.3 billion
Dec. 31, 2024 -114.8 million
June 30, 2024 -152.9 million

2552.HK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 1.2 billion 245.5 million 36.1 million
June 30, 2025 1.1 billion 181.7 million 63.8 million
Dec. 31, 2024 1.2 billion 147.6 million 67.2 million
June 30, 2024 1.4 billion 186.4 million 35.6 million

2552.HK Shares Outstanding

No data available :(

2552.HK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - 87.0 million 177.9 million -
June 30, 2025 - 72.1 million 128.5 million 70.3 million
Dec. 31, 2024 1.0 million 101.4 million 157.2 million 98.0 million
June 30, 2024 1.0 million 128.7 million 131.3 million 65.7 million

2552.HK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 301.4 million 123.6 million
June 30, 2025 238.2 million 109.1 million
Dec. 31, 2024 163.0 million 81.1 million
June 30, 2024 110.3 million 59.0 million

2552.HK

Price: HK$2.32

52 week price:
1.73
4.95

Earnings Per Share: 1.24 HKD

P/E Ratio: 2.37

Exchange: HKG

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 2.9 billion

Links: